KERX
Keryx Biopharmaceuticals Inc
KERX
KERX
Delisted
KERX was delisted on the 12th of December, 2018.
110 hedge funds and large institutions have $508M invested in Keryx Biopharmaceuticals Inc in 2013 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 42 increasing their positions, 37 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
110
Holders Change
+8
Holders Change %
+7.84%
% of All Funds
3.57%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.16%
New
16
Increased
42
Reduced
37
Closed
7
Calls
$31.3M
Puts
$17M
Net Calls
+$14.3M
Net Calls Change
+$27.6M
Top Buyers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$13.2M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$11.5M |
| 3 |
Renaissance Technologies
New York
|
+$10M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$8.28M |
| 5 |
HCM
Harvey Capital Management
Palm Beach,
Florida
|
+$8.27M |
Top Sellers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$33M |
| 2 |
DM
Deerfield Management
New York
|
-$20.3M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$11.9M |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$10M |
| 5 |
Millennium Management
New York
|
-$7.42M |
